Inventor · disambiguated record
Lorenzo Benatuil
Also filed as: BENATUIL LORENZO
22 granted patents·25 pending applications·134 citations·filing 2009–2024
95Inventor score
Top patents by PatentIndex Score
47 records- 0195US9493568B2Anti-EGFR antibodies and antibody drug conjugatesABBVIE INC·Filed 2015·Granted Nov 15, 2016·19 cites·22 claims
- 0290US11639390B2Anti-alpha-4-beta-7 antibodiesABBVIE INC·Filed 2021·Granted May 2, 2023·4 cites·9 claims
- 0390US9132190B2Therapeutic DLL4 binding proteinsABBVIE INC·Filed 2013·Granted Sep 15, 2015·13 cites·46 claims
- 0490US8987419B2Amyloid-beta binding proteinsBARGHORN STEFAN·Filed 2011·Granted Mar 24, 2015·15 cites·11 claims
- 0589US9670276B2IL-1 binding proteinsABBVIE INC·Filed 2013·Granted Jun 6, 2017·15 cites·24 claims
- 0688US10174121B2Anti-CD40 antibodiesABBVIE INC·Filed 2016·Granted Jan 8, 2019·6 cites·21 claims
- 0788US8623358B2Therapeutic DLL4 binding proteinsBENATUIL LORENZO·Filed 2010·Granted Jan 7, 2014·13 cites·44 claims
- 0888US2025163159A1Anti-egfr antibodies and antibody drug conjugatesABBVIE INC·Filed 2024·Application pending·0 cites
- 0987US9226983B2TNF-α binding proteinsBENATUIL LORENZO·Filed 2011·Granted Jan 5, 2016·12 cites·33 claims
- 1085US9827330B2Anti-EGFR antibodies and antibody drug conjugatesABBVIE INC·Filed 2016·Granted Nov 28, 2017·3 cites·21 claims
- 1185US9550986B2High-throughput antibody humanizationABBVIE INC·Filed 2013·Granted Jan 24, 2017·4 cites·14 claims
- 1284US10640563B2Anti-B7-H3 antibodies and antibody drug conjugatesABBVIE INC·Filed 2017·Granted May 5, 2020·3 cites·3 claims
- 1384US9200270B2Methods for transforming yeastHSIEH CHUNG-MING·Filed 2009·Granted Dec 1, 2015·4 cites·15 claims
- 1483US10098968B2Anti-EGFR antibodies and antibody drug conjugatesABBVIE INC·Filed 2017·Granted Oct 16, 2018·2 cites·13 claims
- 1581US9655964B2Bispecific antibodies directed against TNF-α and IL-17ABBVIE INC·Filed 2012·Granted May 23, 2017·6 cites·35 claims
- 1680US9469688B2Therapeutic DLL4 binding proteinsABBVIE INC·Filed 2015·Granted Oct 18, 2016·2 cites·37 claims
- 1778US9803009B2Immunobinders directed against TNFABBVIE INC·Filed 2012·Granted Oct 31, 2017·3 cites·12 claims
- 1878US2022288221A1Anti-egfr antibodies and antibody drug conjugatesABBVIE INC·Filed 2021·Application pending·0 cites
- 1976US9458244B2Single chain multivalent binding protein compositions and methodsABBVIE INC·Filed 2013·Granted Oct 4, 2016·1 cites·31 claims
- 2076US8999331B2Immunobinders directed against sclerostinHSIEH CHUNG-MING·Filed 2012·Granted Apr 7, 2015·4 cites·17 claims
- 2173US9915665B2High-throughput system and method for identifying antibodies having specific antigen binding activitiesABBVIE INC·Filed 2013·Granted Mar 13, 2018·2 cites·44 claims
- 2273US9840554B2Antibodies against platelet-derived growth factor (PDGF)ABBVIE INC·Filed 2016·Granted Dec 12, 2017·2 cites·9 claims
- 2371US2020405878A1Anti-egfr antibodies and antibody drug conjugatesABBVIE INC·Filed 2020·Application pending·0 cites
- 2466US10093733B2LRP-8 binding dual variable domain immunoglobulin proteinsABBVIE INC·Filed 2015·Granted Oct 9, 2018·1 cites·25 claims
- 2566US2019134216A1Anti-egfr antibodies and antibody drug conjugatesABBVIE INC·Filed 2018·Application pending·0 cites
- 2665US2023135723A1Anti-cd98 antibodies and antibody drug conjugatesABBVIE INC·Filed 2022·Application pending·0 cites
- 2765US2022289858A1Anti-cd40 antibodies and uses thereofABBVIE INC·Filed 2021·Application pending·0 cites
- 2865US2020255508A1Therapeutic DLL4 Binding ProteinsABBVIE INC·Filed 2019·Application pending·0 cites
- 2964US2023120736A1Anti-cd98 antibodies and antibody drug conjugatesABBVIE INC·Filed 2022·Application pending·0 cites
- 3059US2018371071A1Therapeutic DLL4 Binding ProteinsABBVIE INC·Filed 2017·Application pending·0 cites
- 3157US2021171637A1Anti-b7-h3 antibodies and antibody drug conjugatesABBVIE INC·Filed 2020·Application pending·0 cites
- 3253US2018094049A1Amyloid-beta binding proteinsABBVIE DEUTSCHLAND·Filed 2017·Application pending·0 cites
- 3353US2019359725A1Anti-cd40 antibodies and uses thereofABBVIE INC·Filed 2018·Application pending·0 cites
- 3452US2020121803A1Anti-cd98 antibodies and antibody drug conjugatesABBVIE INC·Filed 2017·Application pending·0 cites
- 3550US9822171B2Amyloid-beta binding proteinsABBVIE DEUTSCHLAND·Filed 2015·Granted Nov 21, 2017·0 cites·15 claims
- 3650US2014170152A1Immunobinders directed against tnfABBVIE INC·Filed 2013·Application pending·0 cites
- 3750US2016153001A1Methods for transforming yeastABBVIE INC·Filed 2015·Application pending·0 cites
- 3850US2017088611A1Single-chain multivalent binding protein compositions and methodsABBVIE INC·Filed 2016·Application pending·0 cites
- 3949US2014079705A1Bispecific immunobinders directed against tnf and il-17ABBVIE INC·Filed 2013·Application pending·0 cites
- 4048US2014235476A1Multivalent binding protein compositions and methods for identifying variants of sameABBVIE INC·Filed 2013·Application pending·0 cites
- 4147US2020147235A1Anti-cd98 antibodies and antibody drug conjugatesABBVIE INC·Filed 2017·Application pending·0 cites
- 4243US2020338209A1Anti-b7-h3 antibodies and antibody drug conjugatesABBVIE INC·Filed 2017·Application pending·0 cites
- 4343US2016176958A1Tnf-alpha binding proteinsABBVIE INC·Filed 2015·Application pending·0 cites
- 4443US2020002432A1Anti-cd98 antibodies and antibody drug conjugatesABBVIE INC·Filed 2017·Application pending·0 cites
- 4539US2020002421A1Anti-b7-h3 antibodies and antibody drug conjugatesABBVIE INC·Filed 2017·Application pending·0 cites
- 4637US2015266977A1Immunobinders directed against sclerostinABBVIE INC·Filed 2015·Application pending·0 cites
- 4737US2011318349A1Dual variable domain immunoglobulins and uses thereofGHAYUR TARIQ·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lorenzo Benatuil files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →